|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000100949 |
Summary for RABGGTA |
Gene summary |
| Gene information | Ensembl ID | ENSG00000100949 | Gene symbol | RABGGTA |
| Gene name | Rab geranylgeranyltransferase subunit alpha | |
| HGNC | 9795 | |
| Entrez ID | 5875 | |
| Gene type | protein_coding | |
| Synonyms | RABGGTA|PTAR3 | |
| UniProtAcc | Q92696 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000100949 | RABGGTA | DB04464 | N-Formylmethionine | SmallMoleculeDrug |
| ENSG00000100949 | RABGGTA | DB07780 | Farnesyl diphosphate | SmallMoleculeDrug |
| ENSG00000100949 | RABGGTA | DB07841 | Geranylgeranyl diphosphate | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for RABGGTA |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for RABGGTA |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for RABGGTA |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg00951770 | chr14:24272457 | CGI:chr14:24271358-24271736 | promoter | 7.79e-01 | 6.58e-01 | 4.03e+00 | 5.55e-05 | 1.72e-04 | 1.21e-01 |
| THCA | cg18254364 | chr14:24272615 | CGI:chr14:24271358-24271736 | promoter | 8.33e-01 | 9.53e-01 | -5.13e+00 | 2.97e-07 | 1.40e-05 | -1.20e-01 |
| HNSC | cg18254364 | chr14:24272615 | CGI:chr14:24271358-24271736 | promoter | 8.74e-01 | 6.46e-01 | 4.22e+00 | 2.43e-05 | 7.94e-05 | 2.29e-01 |
| LUSC | cg11068517 | chr14:24272504 | CGI:chr14:24271358-24271736 | promoter | 7.84e-01 | 6.40e-01 | 3.85e+00 | 1.19e-04 | 7.52e-04 | 1.44e-01 |
| LUSC | cg18254364 | chr14:24272615 | CGI:chr14:24271358-24271736 | promoter | 8.68e-01 | 6.05e-01 | 4.36e+00 | 1.32e-05 | 5.26e-04 | 2.64e-01 |
| BLCA | cg00951770 | chr14:24272457 | CGI:chr14:24271358-24271736 | promoter | 7.77e-01 | 9.00e-01 | -3.25e+00 | 1.15e-03 | 2.54e-03 | -1.23e-01 |
| ESCA | cg00951770 | chr14:24272457 | CGI:chr14:24271358-24271736 | promoter | 8.29e-01 | 6.80e-01 | 2.43e+00 | 1.50e-02 | 3.82e-02 | 1.49e-01 |
| CHOL | cg18254364 | chr14:24272615 | CGI:chr14:24271358-24271736 | promoter | 8.96e-01 | 7.91e-01 | 3.46e+00 | 5.30e-04 | 8.63e-03 | 1.05e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg00951770 | chr14:24272457 | CGI:chr14:24271358-24271736 | promoter | 8.34e-01 | 6.99e-01 | 2.84e+00 | 4.53e-03 | 1.28e-02 | 1.35e-01 |
| LIHC | cg18254364 | chr14:24272615 | CGI:chr14:24271358-24271736 | promoter | 8.98e-01 | 7.85e-01 | 5.95e+00 | 2.73e-09 | 3.72e-07 | 1.14e-01 |
Top |
Exon skipping events with PSI in TCGA for RABGGTA |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for RABGGTA |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for RABGGTA |
TFs related to RABGGTA.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
RABGGTA related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for RABGGTA |
RBPs related to ES in RABGGTA.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | RBM4 | exon_skip_112058 | 7.46e+00 | 9.86e-01 | 7.01e+00 | 3.94e-03 | Male-biased |
| UVM | RBM4 | exon_skip_112058 | 7.09e+00 | 9.80e-01 | 6.77e+00 | 6.55e-03 | Male-biased |
| LIHC | PCBP2 | exon_skip_112061 | 8.21e+00 | 8.18e-03 | 8.62e+00 | 9.86e-01 | Female-biased |
| COAD | RBM4 | exon_skip_112058 | 7.72e+00 | 9.81e-01 | 7.38e+00 | 9.23e-03 | Male-biased |
| DLBC | KHDRBS2 | exon_skip_112046 | 1.08e+01 | 9.95e-01 | 1.04e+01 | 4.05e-03 | Male-biased |
| DLBC | RBM41 | exon_skip_112042 | 7.16e+00 | 5.27e-03 | 7.55e+00 | 9.84e-01 | Female-biased |
| CHOL | KHDRBS2 | exon_skip_112046 | 1.07e+01 | 9.86e-01 | 1.03e+01 | 1.30e-02 | Male-biased |
| PCPG | PCBP2 | exon_skip_112061 | 8.12e+00 | 1.13e-02 | 8.43e+00 | 9.82e-01 | Female-biased |
| MESO | KHDRBS2 | exon_skip_112046 | 1.02e+01 | 4.67e-03 | 1.07e+01 | 9.94e-01 | Female-biased |
| KIRC | RBM41 | exon_skip_112039 | 8.14e+00 | 8.87e-03 | 8.46e+00 | 9.85e-01 | Female-biased |
| KIRC | RBM41 | exon_skip_112042 | 6.91e+00 | 6.87e-03 | 7.25e+00 | 9.82e-01 | Female-biased |
| KICH | KHDRBS2 | exon_skip_112046 | 1.03e+01 | 1.24e-02 | 1.06e+01 | 9.86e-01 | Female-biased |
| SARC | RBM41 | exon_skip_112042 | 7.53e+00 | 9.83e-01 | 7.12e+00 | 6.31e-03 | Male-biased |
RABGGTA related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs28522221 | chr14:26625602:T:C | - | 0.435811411439443 | 0.00252761196954277 | KIRP | Female-baised eQTL |
| rs17257354 | chr14:24803913:T:C | - | 0.145892906900514 | 0.0422370209037759 | KIRP | Female-baised eQTL |
| rs17111549 | chr14:26707064:A:G | - | 0.306265108169478 | 0.0444286166124531 | KIRP | Female-baised eQTL |
| rs80183982 | chr14:25644315:C:T | - | 0.156326028223133 | 0.0180522190828037 | STAD | Female-baised eQTL |
| rs77815934 | chr14:25646427:C:T | - | 0.156326028223133 | 0.0180522190828037 | STAD | Female-baised eQTL |
| rs61981925 | chr14:25647542:T:C | - | 0.135520000170654 | 0.039728980719394 | STAD | Female-baised eQTL |
| rs17098833 | chr14:32346271:A:G | - | 0.115681969765978 | 0.0025694915228459 | LUAD | Female-baised eQTL |
| rs4981958 | chr14:32372259:C:T | - | -0.0625216494837471 | 0.00999890042882455 | LUAD | Female-baised eQTL |
| rs10136649 | chr14:33421499:T:C | - | 0.0855906578443941 | 0.0108380566430331 | LUAD | Female-baised eQTL |
| rs7145111 | chr14:32369468:C:T | - | -0.0601057450785156 | 0.012840924618914 | LUAD | Female-baised eQTL |
| rs17097881 | chr14:31428568:A:G | - | -0.0689986082116913 | 0.0325782895116078 | LUAD | Female-baised eQTL |
| rs11624231 | chr14:31428910:T:A | - | -0.0686629884258918 | 0.0340808826471241 | LUAD | Female-baised eQTL |
| rs138832021 | chr14:31437522:C:A | - | -0.0685091205620238 | 0.034865025925849 | LUAD | Female-baised eQTL |
| rs56183134 | chr14:31438588:T:C | - | -0.0685091205620238 | 0.034865025925849 | LUAD | Female-baised eQTL |
| rs79360085 | chr14:31449055:G:A | - | -0.0685091205620238 | 0.034865025925849 | LUAD | Female-baised eQTL |
| rs184914683 | chr14:31437306:G:C | - | -0.0685565204149195 | 0.0361807246552917 | LUAD | Female-baised eQTL |
| rs17097896 | chr14:31447491:C:T | - | -0.0681773179277396 | 0.0364369418333877 | LUAD | Female-baised eQTL |
| rs55864289 | chr14:31462597:C:T | - | -0.0678485754448525 | 0.0386457637025112 | LUAD | Female-baised eQTL |
| rs72672691 | chr14:31475041:T:A | - | -0.0675017664898144 | 0.0404188165177356 | LUAD | Female-baised eQTL |
| rs7160175 | chr14:31368564:A:G | - | 0.0721641729145689 | 0.0185550568299188 | COAD | Female-baised eQTL |
| rs12586712 | chr14:31371105:C:A | - | 0.071525446386636 | 0.0198422022491399 | COAD | Female-baised eQTL |
| rs12885363 | chr14:31375079:C:T | - | 0.070059214811752 | 0.0212221552017863 | COAD | Female-baised eQTL |
| rs942907 | chr14:31358870:A:C | - | 0.0713055158168746 | 0.029521233308578 | COAD | Female-baised eQTL |
| rs76619699 | chr14:31366340:T:A | - | -0.0891544429973393 | 0.0295450928317572 | COAD | Female-baised eQTL |
| rs8007411 | chr14:31332324:A:T | - | 0.0720556534730114 | 0.0315497349654119 | COAD | Female-baised eQTL |
| rs8008358 | chr14:31341229:C:T | - | 0.0720556534730114 | 0.0315497349654119 | COAD | Female-baised eQTL |
| rs12883276 | chr14:31378705:A:G | - | 0.0690015074733673 | 0.0339644016813813 | COAD | Female-baised eQTL |
| rs11627179 | chr14:31353959:T:C | - | 0.0699046618975843 | 0.0348406117838625 | COAD | Female-baised eQTL |
| rs7151378 | chr14:31354534:T:C | - | 0.0699046618975843 | 0.0348406117838625 | COAD | Female-baised eQTL |
| rs7156569 | chr14:31354975:T:C | - | 0.0699046618975843 | 0.0348406117838625 | COAD | Female-baised eQTL |
| rs2378852 | chr14:31355156:G:A | - | 0.0699046618975843 | 0.0348406117838625 | COAD | Female-baised eQTL |
| rs2378853 | chr14:31355384:G:A | - | 0.0699046618975843 | 0.0348406117838625 | COAD | Female-baised eQTL |
| rs6571408 | chr14:31328233:T:G | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs6571409 | chr14:31328257:G:A | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs8016487 | chr14:31328525:T:C | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs2094131 | chr14:31332898:C:A | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs11850326 | chr14:31333676:C:T | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs4981838 | chr14:31336930:G:C | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs4595710 | chr14:31337737:T:C | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs8012940 | chr14:31340280:C:T | - | 0.0705873319647323 | 0.037356710042135 | COAD | Female-baised eQTL |
| rs28791187 | chr14:31377484:A:G | - | -0.0842135757046854 | 0.0381037134030399 | COAD | Female-baised eQTL |
| rs4981840 | chr14:31380108:T:C | - | 0.0678481085192399 | 0.0388637576381059 | COAD | Female-baised eQTL |
| rs10130574 | chr14:31330010:C:T | - | -0.0796028303576993 | 0.0390095645218993 | COAD | Female-baised eQTL |
| rs10149123 | chr14:31363818:C:T | - | -0.0873218648633402 | 0.0407763425280229 | COAD | Female-baised eQTL |
| rs74188609 | chr14:31364837:T:C | - | -0.0873218648633402 | 0.0407763425280229 | COAD | Female-baised eQTL |
| rs2378851 | chr14:31333412:C:T | - | 0.0759144589422329 | 0.0448689240862804 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10483437 | chr14:33366595:T:A | - | 0.0395655434293528 | 0.0108889784485638 | KIRC | Male-baised eQTL |
| rs941505 | chr14:24264066:T:A | - | 0.0827221002449859 | 0.00825980779502908 | BLCA | Male-baised eQTL |
| rs860544 | chr14:24765612:G:C | - | -0.072123634971566 | 0.0130611101369934 | BLCA | Male-baised eQTL |
| rs2146571 | chr14:23893209:A:G | - | -0.0596706478764186 | 0.0228723114494413 | BLCA | Male-baised eQTL |
| rs12050347 | chr14:23893061:C:T | - | -0.0574196507625667 | 0.0250773110396458 | BLCA | Male-baised eQTL |
| rs1315995 | chr14:32051280:T:C | - | -0.0587186157842217 | 0.0281374672235126 | BLCA | Male-baised eQTL |
| rs4580080 | chr14:24753926:T:G | - | -0.0583804611103386 | 0.0294365776465152 | BLCA | Male-baised eQTL |
| rs12433059 | chr14:24754355:A:T | - | -0.0583804611103386 | 0.0294365776465152 | BLCA | Male-baised eQTL |
| rs11158417 | chr14:23897072:C:T | - | -0.0545735049447312 | 0.0385985352522846 | BLCA | Male-baised eQTL |
| rs79875511 | chr14:24755708:C:T | - | -0.0568364360813668 | 0.0396501576226976 | BLCA | Male-baised eQTL |
| rs4421908 | chr14:23898149:G:C | - | -0.0543146863652641 | 0.0402714957571384 | BLCA | Male-baised eQTL |
| rs2146572 | chr14:23897841:G:A | - | -0.0542660081469345 | 0.0403538656522677 | BLCA | Male-baised eQTL |
| rs34544775 | chr14:23898385:A:G | - | -0.0542660081469345 | 0.0403538656522677 | BLCA | Male-baised eQTL |
| rs2038653 | chr14:23913862:C:A | - | -0.0545653559815497 | 0.0413192877978415 | BLCA | Male-baised eQTL |
| rs6571502 | chr14:32290326:C:T | - | 0.0509186995573653 | 0.0416235153553298 | BLCA | Male-baised eQTL |
| rs1467587 | chr14:23894941:A:G | - | -0.0541496559828096 | 0.0423075600576439 | BLCA | Male-baised eQTL |
| rs11848301 | chr14:23895418:A:G | - | -0.0538439245690534 | 0.0452488913728472 | BLCA | Male-baised eQTL |
| rs11622978 | chr14:22382662:T:C | - | -0.115779466705448 | 9.13459487896795e-05 | COAD | Male-baised eQTL |
| rs3759614 | chr14:23367892:A:G | - | -0.0873758242518138 | 0.00250028742679956 | COAD | Male-baised eQTL |
| rs1954441 | chr14:31649507:G:A | - | -0.0611614943247133 | 0.00433566816414544 | COAD | Male-baised eQTL |
| rs10483399 | chr14:32338298:G:C | - | -0.103680830398569 | 0.00726195031633343 | COAD | Male-baised eQTL |
| rs12586353 | chr14:27442502:A:C | - | -0.0725565077522473 | 0.00766169007986102 | COAD | Male-baised eQTL |
| rs1885319 | chr14:20822160:T:G | - | -0.0938475989463638 | 0.0107025617892639 | COAD | Male-baised eQTL |
| rs12100478 | chr14:23853598:G:T | - | -0.08170894768653 | 0.0113237924409986 | COAD | Male-baised eQTL |
| rs74036706 | chr14:23854204:A:G | - | -0.08170894768653 | 0.0113237924409986 | COAD | Male-baised eQTL |
| rs11850325 | chr14:27157681:T:G | - | -0.0840109841728498 | 0.0114114818034618 | COAD | Male-baised eQTL |
| rs17434055 | chr14:27159818:C:T | - | -0.0840109841728498 | 0.0114114818034618 | COAD | Male-baised eQTL |
| rs1780880 | chr14:19813305:G:A | - | -0.0933375802482472 | 0.0131331909842454 | COAD | Male-baised eQTL |
| rs10133899 | chr14:20324882:G:A | - | -0.102352780303786 | 0.0140960598161931 | COAD | Male-baised eQTL |
| rs4981378 | chr14:21657833:G:A | - | -0.0786094782112208 | 0.0183485676487555 | COAD | Male-baised eQTL |
| rs12432054 | chr14:21661325:C:T | - | -0.0786094782112208 | 0.0183485676487555 | COAD | Male-baised eQTL |
| rs6573420 | chr14:23864806:A:G | - | 0.0778552904269242 | 0.0195181593257841 | COAD | Male-baised eQTL |
| rs17469830 | chr14:32014919:C:A | - | -0.0691379239385009 | 0.0210327422274105 | COAD | Male-baised eQTL |
| rs11624939 | chr14:27161800:A:T | - | -0.0750221138042526 | 0.0230285238547219 | COAD | Male-baised eQTL |
| rs12885454 | chr14:29267632:C:A | - | 0.0598220812236806 | 0.0248713413131878 | COAD | Male-baised eQTL |
| rs17571634 | chr14:26307276:C:T | - | -0.0568923199062622 | 0.0265508066739517 | COAD | Male-baised eQTL |
| rs35762321 | chr14:21686368:C:A | - | -0.0710207348351717 | 0.0268184509024682 | COAD | Male-baised eQTL |
| rs7141411 | chr14:31800600:C:T | - | -0.0498646732784077 | 0.0275703785663109 | COAD | Male-baised eQTL |
| rs2273171 | chr14:30912145:T:C | - | -0.0503874773931015 | 0.0301001851598476 | COAD | Male-baised eQTL |
| rs7144733 | chr14:21653705:A:G | - | -0.0677820862778348 | 0.0316954946064397 | COAD | Male-baised eQTL |
| rs1243474 | chr14:21121452:A:G | - | -0.115902943495662 | 0.0327517410066492 | COAD | Male-baised eQTL |
| rs116925197 | chr14:20827991:C:G | - | -0.0926844758658984 | 0.0328509763375469 | COAD | Male-baised eQTL |
| rs12882702 | chr14:27133645:G:A | - | -0.05572367214672 | 0.0346315638997148 | COAD | Male-baised eQTL |
| rs17570915 | chr14:26281505:G:A | - | -0.0675815515803907 | 0.0349416349241979 | COAD | Male-baised eQTL |
| rs725891 | chr14:21687544:T:C | - | -0.0702430479364174 | 0.034956395202116 | COAD | Male-baised eQTL |
| rs10431662 | chr14:21690152:C:T | - | -0.0702722879224691 | 0.0352204029435989 | COAD | Male-baised eQTL |
| rs2224685 | chr14:23872174:C:A | - | 0.0545024537140269 | 0.0377004108573653 | COAD | Male-baised eQTL |
| rs4605053 | chr14:21689923:C:T | - | -0.0696528746274088 | 0.0384139914807402 | COAD | Male-baised eQTL |
| rs4491431 | chr14:23868546:C:T | - | 0.0704405567815351 | 0.0464644820497562 | COAD | Male-baised eQTL |
| rs116420067 | chr14:23846006:T:A | - | -0.0709899248384243 | 0.0488456911288622 | COAD | Male-baised eQTL |
| rs34429098 | chr14:27164664:T:A | - | -0.0741394132597371 | 0.0490308702654154 | COAD | Male-baised eQTL |
| rs77669726 | chr14:27168726:C:G | - | -0.0741394132597371 | 0.0490308702654154 | COAD | Male-baised eQTL |
| rs79876505 | chr14:23853931:A:G | - | -0.0707701738751 | 0.0498714990988289 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000100949 | |
| CpG Site: cg11068517 | |
| Position to Gene: promoter | |
| Male Effect: -0.37972357764542 | |
| Female Effect: - |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg11068517 | chr14:24272504 | promoter | -0.37972357764542 | 8.78822813697494e-07 | -0.3791561255766833 | 4.913114259818513e-09 | LUAD |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of RABGGTA |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |